Literature DB >> 3263687

Genetic control of beta-lactamase production in Enterobacter cloacae.

G Korfmann1, B Wiedemann.   

Abstract

In Enterobacter cloacae, mutations in favor of overproduction of beta-lactamase--leading to resistance to third-generation cephalosporins--occur at frequencies of 10(-4)-10(-7). Cloning experiments reveal that at least three genes are involved in the regulation of chromosomal beta-lactamase expression. The structural gene, ampC, is located adjacent to the regulatory gene, ampR, coding for a protein that can serve as an activator in the presence of an inducer. An example of an ampR mutant that is independent of an inducer has been studied. More important for the development of cefotaxime resistance in E. cloacae are mutations in the ampD gene and other proposed regulatory genes. Inactivation of the ampD gene leads to elevated beta-lactamase production. Thus, ampD negatively controls ampC expression. Evidence for the existence of a third regulatory gene, ampE, has been found.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263687     DOI: 10.1093/clinids/10.4.793

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Interference with murein turnover has no effect on growth but reduces beta-lactamase induction in Escherichia coli.

Authors:  A R Kraft; J Prabhu; A Ursinus; J V Höltje
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Role of penicillin-binding proteins in the initiation of the AmpC beta-lactamase expression in Enterobacter cloacae.

Authors:  D Pfeifle; E Janas; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  The signal molecule for beta-lactamase induction in Enterobacter cloacae is the anhydromuramyl-pentapeptide.

Authors:  H Dietz; D Pfeifle; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

4.  Location of N-acetylmuramyl-L-alanyl-D-glutamylmesodiaminopimelic acid, presumed signal molecule for beta-lactamase induction, in the bacterial cell.

Authors:  H Dietz; D Pfeifle; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study.

Authors:  D E Low; J de Azavedo; R Davidson
Journal:  Can J Infect Dis       Date:  1999-03

6.  Osteoarticular Infections Following Open or Penetrating Trauma in Children in the Post-Community-Acquired Methicillin-resistant Staphylococcus aureus Era: The Impact of Enterobacter cloacae.

Authors:  J Chase McNeil; Jesus G Vallejo; Kristina G Hultén; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

7.  Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics.

Authors:  P A Bradford; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

8.  Expression of the AsbA1, OXA-12, and AsbM1 beta-lactamases in Aeromonas jandaei AER 14 is coordinated by a two-component regulon.

Authors:  L E Alksne; B A Rasmussen
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

Review 9.  Cephalosporins--cefotaxime 10 years later, a major drug with continued use.

Authors:  H C Neu
Journal:  Infection       Date:  1991       Impact factor: 3.553

10.  Sequences of wild-type and mutant ampD genes of Citrobacter freundii and Enterobacter cloacae.

Authors:  U Kopp; B Wiedemann; S Lindquist; S Normark
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.